Worldwide Healthcare Trust PLC Stock

Equities

WWH

GB00BN455J50

Investment Trusts

Market Closed - London S.E. 11:35:05 2024-04-24 am EDT 5-day change 1st Jan Change
336.5 GBX +0.90% Intraday chart for Worldwide Healthcare Trust PLC +1.82% +8.20%
Sales 2022 -129M -161M Sales 2023 34.33M 42.78M Capitalization 1.95B 2.43B
Net income 2022 -142M -177M Net income 2023 -8M -9.97M EV / Sales 2022 -17.3 x
Net Debt 2022 87M 108M Net cash position 2023 3M 3.73M EV / Sales 2023 56.7 x
P/E ratio 2022
-15.1 x
P/E ratio 2023
-229 x
Employees -
Yield 2022
0.81%
Yield 2023
1%
Free-Float 96.49%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.90%
1 week+1.82%
Current month+0.45%
1 month+2.44%
3 months+7.68%
6 months+13.11%
Current year+8.20%
More quotes
1 week
325.82
Extreme 325.8152
336.50
1 month
325.04
Extreme 325.0395
336.50
Current year
307.85
Extreme 307.8485
336.50
1 year
286.00
Extreme 286
336.50
3 years
282.00
Extreme 282
392.50
5 years
215.95
Extreme 215.9515
396.50
10 years
123.50
Extreme 123.5
396.50
More quotes
Members of the board TitleAgeSince
Director/Board Member 70 16-02-14
Director/Board Member 55 18-06-06
Director/Board Member - 22-08-31
More insiders
Date Price Change Volume
24-04-24 336.5 +0.90% 1,766,287
24-04-23 333.5 +0.91% 1,443,358
24-04-22 330.5 +1.07% 1,277,581
24-04-19 327 -0.91% 1,648,599
24-04-18 330 -0.15% 1,115,056

Delayed Quote London S.E., April 24, 2024 at 11:35 am EDT

More quotes
Worldwide Healthcare Trust PLC is a specialist investment trust. The Company invests in the global healthcare sector with the objective of achieving a high level of capital growth. It invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. It invests up to 10% of the portfolio, at the time of acquisition, in unquoted securities. It invests approximately 50% of the portfolio in larger companies, and at over 20% of the portfolio in smaller companies. It may invest over 5% of the portfolio, at the time of acquisition, in debt instruments, convertibles and royalty bonds issued by pharmaceutical and biotechnology companies. It may invest over 30% of the portfolio in companies under sectors, such as healthcare equipment and supplies, and healthcare providers and services. Its alternative investment fund manager is Frostrow Capital LLP. OrbiMed Capital LLC is its portfolio manager.
More about the company